WEIFANG, Shandong, China, Feb. 14,
2011 /PRNewswire-Asia-FirstCall/ -- Shengtai Pharmaceutical,
Inc. (OTC Bulletin Board: SGTI) ("Shengtai" or "the Company"), a
leading manufacturer and distributor of high-quality,
pharmaceutical grade glucose products in China, and a manufacturer and distributor in
China of starch products, will
hold a conference call to discuss its 2nd quarter fiscal
year 2011 earnings.
Conference Call
The Company will host a conference call on Tuesday, February 15, 2011 at 7:00 P.M. Eastern Standard Time. A question and
answer session will follow management's presentation. Mr.
Qingtai Liu (Chief Executive Officer), Mr. Yongqiang Wang (Chief Financial Officer), Mr.
Weijie Liu (Vice President), and Ms.
Yukie Gao Ying (Investor Relations
Manager) will be the primary speakers on the call.
To participate, please call the following numbers ten minutes
before the call start time:
Phone Number + 1 (877) 407-8035 (North
America)
|
|
Phone Number + 1 (201) 689-8035
(International)
|
|
|
A replay of the call will be available through Wednesday, February 23, 2011, at 11:59 P.M. Eastern Standard Time. For the replay,
please call:
Phone Number +1 (877) 660-6853 (North
America)
|
|
Phone Number +1 (201) 612-7415
(International)
|
|
Account Number: 286
|
|
Conference ID Number: 367449
|
|
|
About Shengtai Pharmaceutical, Inc.
Shengtai Pharmaceutical, Inc. through its wholly owned
subsidiary, Shengtai Holding, Inc. (SHI), and the Chinese operating
company of Weifang Shengtai Pharmaceutical Co., Ltd., is a
manufacturer and distributor in China of glucose and starch products as
pharmaceutical raw materials, other starch products and other
glucose products such as corn meals, food and beverage glucose. For
more information about Shengtai Pharmaceutical, Inc., please visit
www.shengtaipharmaceutical.com .
For more information,
please contact:
|
|
|
|
Shengtai Pharmaceutical,
Inc.
Ms. Yukie Ying Gao
Investor Relations
Manager
Tel:
+86-536-6295802
Email:
guaipaipai@hotmail.com
|
|
|
|
Investor
Relations
DME Capital LLC
David Elias
Tel:
+1-516-967-0205
Email:
dave@dmecapital.com
|
|
|
SOURCE Shengtai Pharmaceutical, Inc.